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Background: Polychlorinated biphenyls (PCBs), known endocrine disruptors, were banned in 1979 but persist in
the environment. Previous studies are inconsistent regarding prenatal exposure to PCBs and pregnancy outcomes.
We investigated associations between prenatal exposure to PCBs and gestational length and birth weight.
Methods: In a sample of 600 infants (born between 1960 and 1963) randomly selected from Child Health and
Development Studies participants followed through adolescence we measured 11 PCB congeners in maternal post
partum sera (within three days of delivery). Length of gestation was computed from the reported first day of the
last menstrual period (LMP) and delivery date. Linear regression was used to estimate associations between PCB
exposure and gestational age and birth weight, adjusting for potential confounders. PCBs were grouped according
to hypothesized biological action (1b (sum of weak phenobarbital inducers), 2b (sum of limited dioxin activity),
and 3 (sum of CYP1A and CYP2b inducers)) or degree of ortho- substitution (mono, di, tri). Secondary analyses
examined associations between total PCB exposure and exposure to individual congeners.
Results: Each unit increase in mono-ortho substituted PCBs was associated with a 0.30 week decrease
(95% confidence interval (CI) -0.59, -0.016), corresponding to a 2.1 (95% CI −4.13, -0.11) day decrease in length of
gestation. Similar associations were estimated for di-ortho substituted PCBs, (1.4 day decrease; (95% CI −2.9, 0.1))
and group 3 PCBs (0.84 day decrease; (95% CI −1.8, 0.11). We found similar associations in congener specific
analyses and for the sum of congeners.
Conclusions: Our study provides new evidence that PCB exposure shortens length of gestation in humans.
This may have public health implications for population exposures.
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Despite their ban in 1979, polychlorinated biphenyls
(PCBs) remain ubiquitous environmental contaminants
due to their chemical stability and lipophilic properties.
PCBs are biphenyls with one to ten chlorine atoms; the
degree of chlorination determines the stability and lipo-
philicity of any particular PCB congener. This structure
also results in stereochemical resemblance to steroid
hormones. In animal and human studies, PCBs cross the
blood-placenta barrier [1,2]. Fetal exposure to PCBs may
result in adverse pregnancy outcomes such as decreased
length of gestation and decreased birth weight.
Both animal experiments and epidemiological studies
suggest that the developing fetus is vulnerable to the
effects of in utero PCB exposure. Early studies examin-
ing laboratory animals fed PCB rich diets report increased
incidence of fetal resorption and abortion, reduced birth
weight, and fetal growth retardation [3-5]. However, the
dosing in these studies was much higher than the low-
level environmentally relevant doses of today [6]. In
human populations with high PCB exposure during preg-
nancy, such as poisoning incidents [7,8] or occupational
exposure [9], reduced birth weight and gestational length
are reported. Epidemiological evidence examining low-
level environmental exposure is less consistent. Some
studies find PCB exposure to be associated with decreased
birth weight and length of gestation [10-13], although
some but not all had small sample sizes – often fewer than
30 subjects [11,12]. In contrast, other studies find no evi-
dence of association [14-18]. Further, in several early
studies, a high percentage of values for a given PCB con-
gener were under the limit of detection [11,17] making
results less reliable and therefore difficult to interpret.
Varying methods used to characterize PCB exposure
may account for some of the conflicting results. PCBs
were generally used as mixtures (i.e. Arochlor). Many of
the aforementioned studies characterize exposure either
as the sum of all PCB congeners [14,15] or as individual
congeners [14,18]. More recently, congener groupings
were developed to summarize exposure based on either
theoretical mode of action, reflecting the metabolic prop-
erties of the individual congeners, [19,20] or the degree of
chlorine substitution as an indicator of the planarity of
the molecule [21]. Additional grouping methods have
been proposed, however it has been suggested that classi-
fication schemes based on either degree of chlorination
or toxicological properties and enzyme induction may be
the most useful [22]. Nevertheless exposure assessment
is challenging because for many outcomes there is a lack
of knowledge regarding exact biological mechanisms. We
choose to focus on grouping according toxicological func-
tion and degree of chlorine substitution in primary ana-
lyses and explore total exposure and congener specific
exposure in secondary analyses.Here, we test the hypotheses that PCBs are associated
with reduced length of gestation and reduced fetal
growth. In secondary analyses, we also test whether
associations, if any, are mediated by perturbed maternal
thyroid function. We use data from the Child Health
and Development Studies (CHDS) in which exposure
was measured in stored maternal serum samples.
Methods
Study design
The CHDS is a prospective birth cohort designed to ob-
serve women, their pregnancies and their offspring [23].
The cohort recruited members of the Kaiser Health Plan
who were receiving obstetric care at the Oakland Cali-
fornia Kaiser Foundation Hospital and nearby East Bay
clinics from 1959 through 1966. Women were enrolled
at the confirmation of their pregnancies and followed
through delivery. The CHDS includes data on 20,754
pregnancies and 19,044 live births. All live births were
followed through at least age 5 years, with some subsets
of children whose families remained in the San Francisco
Bay area being observed through adolescence. At
12 months only 48 (0.2%) subjects were lost to follow
up and at 5-years 89.4% were still under observation.
Detailed information on maternal and paternal char-
acteristics was obtained through maternal interview.
Maternal and pediatric medical records were abstracted to
obtain information about maternal prenatal care measures,
labor and delivery, and child’s serial growth (weight and
height) through age 5. Serum samples were collected from
the women during each trimester of pregnancy and post-
partum. After fractionation, serum samples were frozen at
−20°C, stored and archived. Subjects provided informed
consent in accordance with practices in the 1960s.
The data in the present analysis are derived from
a study of organochlorine compounds (OCs), thyroid
hormone levels and neurocognitive outcomes at ages 5,
9–11 and 15–17. The study base for the present analysis
is drawn from a subset of CHDS children who partici-
pated in neurocognitive examinations through successive
follow-up at ages 5, 9–11 and 15–17 (n = 1752). Of these
participants, we analyzed a sample of 600 infants (300
male, 300 female). The 600 were selected at random
from the 500 males and 453 females who remained eli-
gible after excluding subjects with inadequate second tri-
mester sera (for the measurement of thyroid hormones),
inadequate postpartum maternal serum (for the meas-
urement of OCs) and subjects with missing gestational
age. Pregnancy serum samples used for this analysis
were drawn between 1960–1963.
Laboratory analyses
All serum samples were stored at −20°C, with minimal
thaw-refreeze cycles, until analyzed in 2007–2008. OCs
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tum (within three days of delivery) from the mother.
Serum levels of 11 PCB congeners (66, 74, 99, 118, 138,
153, 170, 180, 187, 194 and 203) were measured. Serum
levels of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane
(p,p′-DDT), 1,1′-dichloro-2,2’-bis(p-chlorophenyl)ethyl-
ene (p,p′-DDE) and 1,1,1-trichloro-2-(p-chlorophenyl)-
2-(o-chlorophenyl)-ethane (o,p′-DDT) were also measured.
Assays were performed at the Environmental Chemistry
Laboratory (ECL) of the California Department of Toxic
Substances Control (n=480) or at the Mount Sinai School
of Medicine (MSSM. n=120). Assay methods are detailed
in a previous publication [24]. Serum triglyceride and
cholesterol levels were measured in the laboratory of
Dr. Nadir Rafai at Harvard Medical School.
Previous reports have established that a wide array of
OCs are detectable in CHDS serum and measures be-
tween laboratories are comparable [25,26]. Inter batch
coefficients of variations (CV) were calculated both for
study subjects and quality control (QC) samples. A com-
parison of CV ratios (study subjects vs QC samples)
between the two laboratories indicates that for all but
two PCB congeners (66 and 99) both had a CV ratio
above two [26], demonstrating that measurement error
is small relative to natural variation found in the data.
The limits of detection (LOD) for both laboratories
ranged from 0.01 to 0.07 ng/mL and 94% of samples
were above the respective LODs for PCB congeners.
As in our previous work [27] PCB values below the
LOD were used as measured rather than recoding them
to the LOD.
Maternal thyroid function during pregnancy was
assessed using FT4 and TSH measured in archived sam-
ples taken in the second trimester. All thyroid assays
were performed at Children’s Hospital/Harvard Medical
School. FT4 and TSH were measured using immunoas-
says on the Roche E Modular system (Roche Diagnos-
tics, Indianapolis, IN). For FT4, the detection limit is
0.023 ng/dL and the day-to-day imprecision values at
concentrations of 0.68, 1.64 and 3.94 ng/dL are 3.5, 3.3
and 6.6%, respectively. For TSH, the detection limit is
0.005 uIU/mL and the day-to-day imprecision values
at concentrations of 0.084, 0.91 and 3.96 uIU/mL are
5.4, 2.1 and 1.8%, respectively. In a preliminary study
(Factor-Litvak, unpublished data), we found that second
trimester serum samples from pregnant women stored
at −20 C for approximately 20 years had values of total
T4 and TSH comparable to that of fresh sera.
Classification of exposure variables
Individual PCB congeners were aggregated into group
variables in two ways. First, measured PCBs were placed
into three groups, according to their degree of chlorine
substitution on the ortho position of the moleculePCBmono (66, 74, 118), PCBdi (99, 138, 153, 170, 180)
and PCBtri (187, 203) [21]; we hypothesized that higher
degrees of ortho chlorination (i.e. less coplanar mole-
cules) would be more likely to act as thyroid hormone
disruptors. Congeners were also grouped according to
proposed biological mechanism [19]: Group 1b, those
potentially estrogenic (187), Group 2b, those with lim-
ited dioxin-like potential (138, 170) and Group 3, those
which inhibit CYP1A and CYP2B (99, 153, 180 and
203). In secondary analyses, exposure was defined as
individual congeners and as the sum of all congeners.
We also categorized all PCB measures into tertiles,
based on the rank order, to explore the shape of the dose
response relationships.
Description of prenatal outcomes
Infant birth weight and length of gestation were
extracted from medical records. Length of gestation was
determined by mothers’ self-reported last menstrual
period and recorded delivery date. There were 14
women in the sample with gestational length greater
than 44 weeks; excluding these women did not change
the findings.
Birth weight in grams and length of gestation in weeks
were examined as continuous measures and were the
primary outcomes in the study. We also calculated
percentile birth weight for gestational age, using race
stratified tables [28]. In a secondary analysis, we exam-
ined preterm delivery (delivery <37 weeks gestation) as
an outcome.
Description of potential covariates
Potential covariates included maternal race, smoking sta-
tus, occupation, education, age, BMI, parity and infant
sex. Where possible, covariates were analyzed as con-
tinuous variables in regression models (i.e. maternal age
and BMI), although for descriptive tables all variables
were expressed categorically. Categories of variables
included maternal race (white, black, and mixed-race
/other), smoking (never, former, and current), occupa-
tion (employed and house-wife/part-time worker), edu-
cation (less than a high-school diploma, a high school
diploma only, a high school diploma and some college
or trade school, and 4-year college degree), age at study
pregnancy (15–24, 25–29, 30–34, and ≥ 35 years), BMI
(underweight (<18.5 kg/m2), normal weight (18.5-
24.99 kg/m2), overweight (25–29.99 kg/m2), and obese
(≥30 kg/m2)), parity (0, 1, 2, and ≥3) and infant sex
(male and female). Pre-pregnancy measures of maternal
weight were limited by sample size (N= 400) so BMI in
our sample reflects weight of the mother at interview or
first prenatal visit (N= 583). Pre-pregnancy and first visit
BMIs were highly correlated since many women had
early enrollment and/or early prenatal care (means for
Kezios et al. Environmental Health 2012, 11:49 Page 4 of 13
http://www.ehjournal.net/content/11/1/49the two time periods were 22.2 vs 23.2 kg/m2, respect-
ively; correlation coefficient: r = .94, p<0.0001). p,p′-DDE
was also examined as a covariate, as it was in Long-
necker, et al. [15].
Statistical analysis
The distributions of all variables were examined. The
variables with skewed distributions were transformed to
reduce impact of extreme values. OC concentrations
were transformed using the natural logarithmic function
and TSH concentrations were transformed using the
square root function. We performed all analysis both
with non-transformed and natural log-transformed PCB
exposures and the interpretation of results did not sub-
stantially differ; thus, we report in text the simpler
results of analyses using non-transformed PCBs (how-
ever, see Additional file 1 Tables S3 and S4 for results of
linear regression analyses using natural-log transformed
PCB exposures). Correlations between individual PCB
congeners, PCB groupings and p,p′-DDE were also
examined using the Spearman’s rank correlation coeffi-
cients. Preliminary analyses compared the 600 infants
selected for the study to those not selected using Chi-
squares for categorical variables and t-tests for con-
tinuous variables.
We used multiple linear regression analysis to assess
the associations between each exposure and outcome,
with and without adjustment for potential confounders.
Potential confounders were selected based on those
previously reported to be associated with the outcome in
the literature or those known to confound the relation-
ship between PCBs and pregnancy outcomes. These
included infant sex, maternal age, race, education, BMI,
occupation, marital status, parity, smoking status and
exposure to p,p′-DDE. All models adjusted for the lab
(ECL vs. MSSM) in which PCBs were measured, and
serum triglycerides and cholesterol (which were trans-
formed using the natural logarithmic function) [29].
Potential covariates were included in a ‘core’ regression
model if they were associated with the outcome. The
core regression model did not include the exposure of
interest. After exposure was included, covariates were
deleted from final regression models if their exclusion
resulted in an unsubstantial change (<0.5 standard
error) in the estimated regression coefficient relating
exposure to outcome. Final linear models for birth
weight adjusted for the following covariates: maternal
race, age, smoking status and BMI, infant sex, linear and
quadratic terms for length of gestation centered at its
mean. Linear models for gestational age adjusted birth
weight percentiles were adjusted for maternal age, smok-
ing status and BMI, and infant sex. Linear models for
length of gestation were adjusted for maternal race, age,
employment status and infant sex.We also used Cox proportional hazards models to esti-
mate the hazard ratio indicating the change in probabil-
ity of giving birth on the next day per unit increase in
exposure, with higher hazard ratio indicative of shorter
gestational length.
We excluded subjects missing covariates (N= 21, 21,
and 8 for the birth weight, birth weight percentile and
length of gestation outcomes, respectively). For an add-
itional 22 women, OC, total cholesterol and triglyceride
concentrations were unable to be measured. These sub-
jects did not differ from the remaining on important
variables, including the outcomes. Further taking into
consideration exclusion of the 14 participants with
length of gestation greater than 44 weeks, final sample
sizes for birth weight, birth weight percentile and length
of gestation models were 556, 543, and 543 respectively.
We examined whether the associations between PCBs
and birth outcomes were mediated by maternal thyroid
function using linear regression analysis [30]; that is we
examined whether maternal thyroid function was in the
pathway between PCB exposure and birth outcomes.
In these analyses, FT4 and TSH were included separately
in the regression models. We considered the following
as evidence for mediation: (1) associations between FT4
and/or TSH and PCBs, (2) associations between FT4
and/or TSH and length of gestation and/or birth weight,
and (3) reductions in the estimated regression coefficient
for PCBs when FT4 and/or TSH is added to the model.
Final analyses examined sex specific associations
between exposures and each birth outcome as reported
previously [15,31].
All analyses were performed using SAS version 9.2.
Results
Our sample had a mean birth weight of 3387 g and
mean gestational age of 40.2 weeks (Table 1). Compari-
sons between the 600 randomly selected subjects and
those not selected show no significant differences in
most of the relevant variables (birth weight, number of
previous live births, percent male infants, mothers’ edu-
cation at birth, mothers’ smoking status during preg-
nancy). However, gestation in those selected for analysis
was significantly longer (by 3 days) compared to those
not selected (p<0.001). In Table 2, the distributions of
maternal concentrations of PCB groupings and individ-
ual PCB are displayed. Nearly all (94%) congeners were
well above the limits of detection and the range of con-
centrations of PCB groupings and individual congeners
were comparable to other studies performed at the time
[32]. Concentrations of PCBs were higher in older
women and those with a college education and lower in
white mothers (Table 3). PCB concentrations did not
decline with parity, reflecting continuing exposure dur-
ing the 1960s; we also note that few women (38.7%) in
Table 1 Comparison of key variables at study baseline between those selected into the study and those not selected
from the Adolescent Study
Variable Selected (N = 600) Not Selected (N = 1420)
N Mean Std N Mean Std p-value
Birth weight (g) 600 3387.8 493.3 1420 3353.7 533.0 0.92
Gestation (days; LMP to term) 600 282.1 12.7 1404 279.1 16.3 <.001
Number of Previous Live Births 600 1.7 1.7 1420 1.9 1.8 0.09
N % N % p-value
Male 300 50.0 703 49.5 0.84
Mother Education at Child’s Birth
< High School 74 12.3 169 11.9 0.58
High School Graduate 202 33.7 477 33.6
Some College/Trade School 200 33.3 444 31.3
College Graduate or Higher 123 20.5 329 23.2
Missing 1 0.2 1 0.1
Maternal Smoking During Pregnancy
Never Smoked 315 52.5 662 46.6 0.16
Smokes Now 180 30.0 490 34.5
Smoked Until Current Pregnancy 40 6.7 119 8.4
Former Smoker 61 10.2 136 9.6
Missing 4 0.7 13 0.9
Data are presented as number, (N), mean and standard deviation (std).
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the OC burden in new mothers. No significant associa-
tions were found between any PCB exposure variable
and birth weight (Table 4) or birth weight percentile
(data not shown) either before or after adjustment for
potential confounders. Further, we did not find signifi-
cant associations between PCB exposure and preterm
delivery (Additional file 1 Table S1), though the number
of preterm deliveries in our sample was small (N = 21;
mean gestation for preterm deliveries: 35.8 ± 1.05 weeks;
range: 32.6 – 36.9 weeks).
We found consistent reductions in length of gestation
related to PCB exposure, regardless of exposure cate-
gorization (Table 5). For example, decreases in length of
gestation were found for mono-ortho substituted PCBs
(0.30 week decrease (95% CI −0.59, -0.016)) for each
unit change in the exposure variable. Decreases of
slightly smaller magnitude were observed for di-ortho
substituted PCBs (0.12 week decrease (95% CI −0.25,
0.017)), and PCBs in group 3 (0.20 week decrease (95%
CI −0.42, 0.014)). For the sum of PCBs, each unit change
of in utero exposure was associated with an adjusted
reduction of approximately 0.10 weeks of gestation (95%
CI −0.19, -0.0016). Consistent results were found in the
analysis using Cox- proportional hazards models (Add-
itional file 1 Table S2a). For example, the covariate-
adjusted hazard ratio for delivery on the next day for
each unit change of di-ortho substituted PCB concentra-
tion was 1.07 (95% CI 1.00, 1.16). Lastly, results wereessentially unchanged when natural log-transformed PCB
variables are used as continuous exposure in regression
models (Additional file 1 Tables S3 and S4).
After collapsing exposure into tertiles, we found that
the magnitude of decreased length of gestation was most
pronounced comparing the highest tertile of PCB expos-
ure to the lowest tertile of exposure in linear regression
models (Figure 1). Results from the Cox proportional
hazards models were consistent (Additional file 1 Table
S2b). For example, the covariate-adjusted hazard ratio
for delivery on the next day comparing the highest ter-
tile of di-ortho substituted PCB concentration to the
lowest was 1.29 (95% CI 1.04, 1.59); comparing the sec-
ond highest tertile of di-ortho substituted PCB concen-
tration to the lowest gives a hazard ratio of 0.99 (95%CI
0.80, 1.23).
We also performed separate analyses relating birth out-
comes with exposure to OC pesticides and their metabo-
lites (p,p′-DDT, o,p′-DDT and p,p′-DDE), and found an
association only for p,p′-DDE and gestational length
(unpublished observations). Thus, secondary analyses
were run adding p,p′-DDE to the models as a potential
confounder. Regression results were not substantially
attenuated and remained consistently in the negative dir-
ection, albeit of lesser statistical significance (Table 5).
We found no evidence of mediation by maternal FT4
or TSH levels; neither FT4 nor TSH were associated
with exposure and neither altered the parameter esti-
mate when included in the regression model as a
Table 2 Distribution of maternal PCB concentrations




1 578 2.37 2.96 3.82 3.30 ± 1.53 0.57 12.29
P
PCBmono
2 578 0.52 0.68 0.92 0.81 ± 0.52 0.13 6.82
P
PCBdi
3 578 1.57 2.00 2.60 2.23 ± 1.05 0.40 8.98
P
PCBtri
4 578 0.18 0.24 0.32 0.26 ± 0.15 0.02 1.90
P
PCB1b
5 578 0.11 0.15 0.20 0.17 ± 0.09 0.02 0.83
P
PCB2b
6 578 0.56 0.72 0.96 0.82 ± 0.44 0.17 3.85
P
PCB3
7 578 1.08 1.37 1.77 1.51 ± 0.66 0.23 5.29
PCB66 578 0.05 0.08 0.13 0.15 ± 0.23 0.01 2.05
PCB 74 578 0.12 0.17 0.24 0.20 ± 0.17 0.01 3.07
PCB 99 578 0.12 0.18 0.25 0.21 ± 0.15 0.01 1.18
PCB 118 579 0.31 0.40 0.53 0.46 ± 0.26 0.08 2.47
PCB 138 579 0.45 0.57 0.77 0.66 ± 0.36 0.13 3.23
PCB 153 579 0.50 0.65 0.85 0.73 ± 0.35 0.14 2.95
PCB 170 578 0.10 0.14 0.19 0.16 ± 0.09 0.01 0.72
PCB 180 579 0.33 0.44 0.56 0.47 ± 0.2 0.08 1.71
PCB 187 578 0.11 0.15 0.20 0.09 ± 0.09 0.02 0.83
PCB 194 459 0.06 0.08 0.11 0.09 ± 0.05 0.06 0.48
PCB 203 578 0.06 0.09 0.13 0.10 ± 0.08 0.01 1.27
FT4 (ng/dL) 600 1.13 1.23 1.38 1.26 ± 0.21 0.76 2.46
TSH (μIU/mL) 600 0.86 1.29 1.92 1.53 ± 1.16 0.005 12.55
+All PCBs are in units of ng/mL.
1PCB congeners summed into PCBtotal: all congeners with LOQ >90% except PCB194 due to large number of missing values.
2PCB congeners summed into PCBmono: 66, 74, 118.
3PCB congeners summed into PCBdi: 99, 138, 153, 170, 180.
4PCB congeners summed into PCBtri: 187, 203.
5PCB congeners summed into PCB1b: 187.
6PCB congeners summed into PCB2b: 138, 170.
7PCB congeners summed into PCB3: 99, 153, 180, 203.
#LODs were different for the two labs; the most conservative LODs are reported in the table (from the MSSM lab, n = 120). LODs for the ECL (n = 460) range from
0.01 to 0.03, with 99% of samples above LODS for the various congeners. LODs are reported in ng/mL.
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gender specific analyses. Tests for interaction of expo-
sure by infant sex on the outcomes using regression
analysis were negative (data not shown).
Discussion
Overall, we found evidence of an inverse association be-
tween maternal exposure to PCBs and length of gesta-
tion. The association was most prominent for the
highest levels of PCB exposure. The direction of associa-
tions for PCB groupings, individual congeners and the
total sum of all congeners was highly consistent which
increases our confidence in the results. While various
grouping methods have been proposed, the consistency
in parameter estimates in our study – regardless of
exposure metric used – suggests that PCBs in our sam-
ple operate to decrease gestation via a similar underlying
mechanism regardless of hypothesized differences in
mechanism of action. We observed no associations
between birth weight and prenatal exposure to PCBs.Previous studies relating PCBs and birth outcomes are
inconsistent. Patandin et al. [10] and Fein et al. [11] find
inverse associations between PCB exposure and birth
weight; Hertz-Picciotto et al. [31] find gender specific
inverse associations, with only boys showing decreased
birth weight and only girls showing shorter gestational
age. Relationships between preterm delivery (defined as
<37 weeks) and OC exposure also have been reported
[11,12,33]. However, there are equally as many studies
reporting no such associations [14-18]. Several factors
may account for these inconsistencies. First, associations
may only be evident where exposure is high; for
example, associations with birth weight are more often
reported in study populations with higher background
exposure to PCBs [34]. Second, different PCB congeners
are measured and in some cases, the congeners are clas-
sified differently. Differences in the toxicities of particular
congener mixtures may contribute to inconsistent results
and make comparisons between studies difficult [15],
particularly in conjunction with different background
Table 3 Concentrations of PCB groupings (mean± SD) by study sample characteristics (n = 578)1
Sample Characteristics PCBtotal PCBmono PCBdi PCBtri PCB1b PCB2b PCB3
Total sample 3.30 ± 1.53 0.81 ± 0.52 2.23 ± 1.05 0.27 ± 0.15 0.17 ± 0.09 0.82 ± 0.44 1.51 ± 0.66
Maternal race
White} 3.21 ± 1.34 0.80 ± 0.46 2.15 ± 0.90 0.26 ± 0.14 0.16 ± 0.08 0.78 ± 0.37 1.47 ± 0.58
Black 3.32 ± 1.79 0.74 ± 0.41 2.31 ± 1.35 0.30 ± 0.17 0.18 ± 0.11 0.89 ± 0.57 1.51 ± 0.82
Other 4.02 ± 2.07* 1.06 ± 0.92* 2.64 ± 1.30* 0.27 ± 0.16 0.21 ± 0.11* 0.99 ± 0.53* 1.76 ± 0.81
Sex of infant
Male} 3.26 ± 1.58 0.79 ± 0.58 2.21 ± 1.03 0.26 ± 0.17 0.16 ± 0.09 0.82 ± 0.42 1.49 ± 0.65
Female 3.35 ± 1.49 0.83 ± 0.45* 2.24 ± 1.07 0.27 ± 0.13 0.17 ± 0.09 0.82 ± 0.45 1.52 ± 0.66
Maternal smoking status
Never} 3.33 ± 1.57 0.82 ± 0.45 2.25 ± 1.13 0.27 ± 0.13 0.17 ± 0.09 0.84 ± 0.48 1.51 ± 0.70
Current 3.28 ± 1.29 0.79 ± 0.48 2.22 ± 0.82 0.27 ± 0.13 0.16 ± 0.08 0.80 ± 0.33 1.53 ± 0.55
Former 3.26 ± 1.85 0.83 ± 0.75 2.17 ± 1.17 0.27 ± 0.22 0.16 ± 0.10 0.80 ± 0.49 1.47 ± 0.74
Maternal occupation
Employed 3.25 ± 1.43 0.79 ± 0.46 2.20 ± 0.96 0.26 ± 0.13 0.16 ± 0.09 0.81 ± 0.39 1.49 ± 0.62
Housewife/Part-time} 3.32 ± 1.59 0.82 ± 0.55 2.23 ± 1.10 0.27 ± 0.16 0.17 ± 0.09 0.83 ± 0.47 1.51 ± 0.68
Maternal education†
No HS diploma 3.16 ± 1.47 0.76 ± 0.40 2.14 ± 1.03 0.26 ± 0.16 0.17 ± 0.10 0.80 ± 0.42 1.43 ± 0.67
HS diploma only} 3.10 ± 1.26 0.76 ± 0.37 2.10 ± 0.91 0.25 ± 0.13 0.15 ± 0.09 0.77 ± 0.37 1.42 ± 0.57
HS + some college 3.34 ± 1.62 0.79 ± 0.45 2.28 ± 1.17 0.28 ± 0.17 0.17 ± 0.09 0.85 ± 0.50 1.54 ± 0.72
College graduate 3.64 ± 1.77 0.96 ± 0.80* 2.39 ± 1.05* 0.29 ± 0.13 0.17 ± 0.08 0.88 ± 0.44 1.63 ± 0.66*
Maternal age categories
15-24 3.03 ± 1.32 0.74 ± 0.38 2.07 ± 0.97 0.23 ± 0.12 0.14 ± 0.09 0.76 ± 0.42 1.39 ± 0.59
25-29} 3.34 ± 1.56 0.79 ± 0.44 2.28 ± 1.09 0.27 ± 0.14 0.17 ± 0.09 0.84 ± 0.45 1.54 ± 0.70
30-34 3.42 ± 1.65 0.84 ± 0.50 2.31 ± 1.18 0.27 ± 0.12 0.17 ± 0.08 0.86 ± 0.51 1.55 ± 0.72
≥35 3.48 ± 1.59 0.90 ± 0.75 2.26 ± 0.91* 0.32 ± 0.20 0.19 ± 0.10 0.82 ± 0.35 1.56 ± 0.60
Maternal BMI categories
Underweight 3.17 ± 1.24 0.68 ± 0.32 2.21 ± 0.88 0.28 ± 0.15 0.17 ± 0.09 0.78 ± 0.34 1.54 ± 0.56
Normal} 3.42 ± 1.62 0.84 ± 0.57 2.30 ± 1.10 0.28 ± 0.16 0.17 ± 0.09 0.85 ± 0.46 1.56 ± 0.69
Over-weight 3.02 ± 1.35 0.73 ± 0.36 2.05 ± 0.99 0.24 ± 0.12 0.15 ± 0.08 0.76 ± 0.41 1.38 ± 0.62
Obese 3.01 ± 1.42 0.85 ± 0.45 1.93 ± 0.91 0.23 ± 0.14 0.15 ± 0.09 0.72 ± 0.39 1.29 ± 0.59*
Parity
0} 3.21 ± 1.49 0.76 ± 0.41 2.20 ± 1.06 0.25 ± 0.14 0.16 ± 0.09 0.81 ± 0.45 1.48 ± 0.65
1 3.22 ± 1.58 0.83 ± 0.69 2.13 ± 0.96 0.25 ± 0.11 0.16 ± 0.07 0.77 ± 0.39 1.45 ± 0.61
2 3.46 ± 1.33 0.83 ± 0.43 2.34 ± 0.89* 0.30 ± 0.13* 0.18 ± 0.09 0.86 ± 0.36 1.59 ± 0.58
≥3 3.36 ± 1.66 0.83 ± 0.47 2.26 ± 1.21 0.28 ± 0.19 0.17 ± 0.10 0.85 ± 0.51 1.52 ± 0.76
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tibility to PCB toxicity in particular populations may
result in discrepant findings.
Our results for length of gestation are in agreement
with some previous studies, but not with others. One
early study reported a significant decrease in gestational
age comparing cord serum PCB concentrations above
the limit of detection (≥3 ng/mL, n = 75) to those below
(<3 ng/mL, n = 166). However, only congeners presentin Arochlor 1260 were measured, and the majority of
subjects had levels below the limit of detection; mean
cord serum PCB levels were 2.5 ± 1.9 ng/mL [11]. In a
New York based case–control study of 20 preterm deliv-
eries and matched controls (delivered between October
1990 and August 1993), no association was observed
between exposure to 12 PCB congeners (82/151, 118,
153, 141, 138, 187, 183, 174, 156, 180, 170, 203) and pre-
term delivery [14]. This study too was hindered by
Table 4 Associations between non-transformed PCB exposure and birth weight
Unadjusted Adjusted Further adjusted for p,p′-DDE
bunadjusted
1 95%CI badjusted
2 95% CI b3adjusted 95%CI
PCB groupings
PCBtotal −4 (−33, 25) 11 (−15, 38) 16 (−15, 46)
PCBmono 24 (−63, 110) 36 (−43, 115) 41 (−42, 125)
PCBdi −16 (−57, 26) 11 (−27, 49) 17 (−27, 60)
PCBtri 77 (−219, 374) 162 (−115, 439) 215 (−96, 527)
PCB1b −26 (−508, 456) 243 (−210, 696) 341 (−180, 863)
PCB2b −26 (−124, 72) 34 (−56, 124) 47 (−54, 148)
PCB3 −24 (−91, 42) 17 (−44, 79) 26 (−45, 98)
Individual PCBs
PCB 66 22 (−204, 247) 27 (−176, 231) 31 (−177, 239)
PCB 74 57 (−187, 302) 134 (−89, 356) 146 (−84, 376)
PCB 99 −137 (−431, 158) 9 (−256, 275) 15 (−263, 294)
PCB 118 51 (−117, 218) 55 (−98, 209) 62 (−99, 222)
PCB 138 −16 (−136, 104) 52 (−58, 162) 68 (−55, 191)
PCB 153 −61 (−187, 65) 20 (−95, 136) 29 (−102, 160)
PCB 170 −245 (−719, 228) 56 (−379, 491) 86 (−401, 574)
PCB 180 0.24 (−217, 218) 112 (−89, 313) 163 (−75, 400)
PCB 187 −26 (−509, 456) 243 (−210, 696) 341 (−180, 863)
PCB 194 23 (−1005, 1051) 311 (−669, 1292) 601 (−468, 1669)
PCB 203 339 (−245, 924) 271 (−271, 812) 310 (−259, 878)
1Parameter estimate for non-transformed PCB measure (adjusted: laboratory, natural log-transformed serum triglycerides and cholesterol).
2Parameter estimate for non-transformed PCB measure (adjusted: maternal race, age, smoking status and BMI, infant sex, length of gestation (centered), quadratic
length of gestation (centered), laboratory and natural log-transformed serum triglycerides and cholesterol).
3Parameter estimate for non-transformed PCB measure (adjusted: p,p′-DDE, maternal race, age, smoking status and BMI, infant sex, length of gestation (centered),
quadratic length of gestation (centered), laboratory and natural log-transformed serum triglycerides and cholesterol).
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http://www.ehjournal.net/content/11/1/49detection limits (the authors state that many PCB mea-
surements were below the limit of detection). Median
levels of congener 180 were 0.17 ng/mL (range: 0.05,
0.45) for cases and 0.19 (range: 0.08, 0.62) for controls,
whereas our study reported a median PCB 180 value of
0.44 (range: 0.08, 1.71).
More recently, Wolff et al. [16] assessed PCB exposure
in maternal plasma in the Children’s Environmental
Health Study, an ethnically diverse New York cohort
established between 1998 and 2002. Exposure was exam-
ined as the sum of congeners 118, 138, 153 and 180,
similar to our di-ortho substituted PCB group (except
for PCB 170). They found no associations between PCBs
and either birth weight or length of gestation in a sam-
ple of 404 participants; however, exposure levels were
very low (median total PCB< 1 ng/mL). The median
value of the di-ortho substituted PCB group in our sam-
ple was 2.00 ng/mL, and over 95% of our sample had a
concentration above 1 ng/mL (range: 0.40, 8.98 ng/mL);
exclusion of congener 170 (median: 0.14 ng/mL; range:
0.01, 0.72 ng/mL) from our group does not alter this
comparison. Mean total PCB concentration in our sam-
ple (2.96 ng/mL) is similar to that found by Longnecker
et al. [15] who examined the association between PCBexposure (median total PCBs = 2.8 ng/ml) and birth out-
comes in the National Collaborative Perinatal Project
(NCPP), a prospective cohort of pregnant women
recruited from 1959–1965. These investigators found
unadjusted associations between maternal third trimes-
ter total PCB (highest quartile, ≥ 4 ng/ml, compared to
the lowest quartile, < 2 ng.ml) and preterm birth
(n = 132 vs n = 902 normal deliveries). After adjustment
for p,p′-DDE and other potential confounders, the odds
ratio diminished to 1.1 (95% CI 0.6, 2.2). We note that
few pregnancies in our sample were preterm, making it
difficult to confirm this result.
Our results for birth weight differ from other large
samples in cohorts established around the same time.
In the Longnecker et al. [15] study described above,
associations between prenatal PCB exposure (sum of
the congeners measured) and small-for-gestational age
(SGA) infants were found and these associations were
more pronounced among boys. In our study we saw no
associations with birth weight or birth weight percentiles
and no associations by sex.
In a different sample of infants drawn from the CHDS,
Hertz-Picciotto et al. [31] found an overall suggestion
of reduced birth weight with higher PCB exposure
Table 5 Associations between non-transformed PCB exposure and length of gestation
Unadjusted Adjusted Further adjusted for p,p′-DDE
bunadjusted
1 95%CI badjusted
2 95% CI b3adjusted 95%CI
PCB groupings
PCBtotal −0.096
* (−0.19, -0.0021) −0.096* (−0.19, -0.0016) −0.087 (−0.20, 0.022)
PCBmono −0.26
+ (−0.54, 0.025) −0.30* (−0.59, -0.016) −0.27+ (−0.57, 0.031)
PCBdi −0.13
+ (−0.27, 0.0035) −0.12+ (−0.25, 0.017) −0.099 (−0.25, 0.057)
PCBtri −0.41 (−1.38, 0.55) −0.54 (−1.53, 0.44) −0.31 (−1.43, 0.80)
PCB1b −1.17 (−2.76, 0.42) −1.09 (−2.72, 0.54) −0.75 (−2.63, 1.14)
PCB2b −0.29
+ (−0.61, 0.031) −0.24 (−0.56, 0.081 −0.18 (−0.55, 0.18)
PCB3 −0.21
+ (−0.42, 0.011) −0.20+ (−0.42, 0.014) −0.18 (−0.43, 0.077)
Individual PCBs
PCB 66 −0.70+ (−1.42, 0.0095) −0.89* (−1.60, -0.18) −0.83* (−1.56, -0.11)
PCB 74 −0.56 (−1.35, 0.24) −0.58 (−1.38, 0.22) −0.47 (−1.30, 0.36)
PCB 99 −0.59 (−1.55, 0.37) −0.48 (−1.43, 0.48) −0.32 (−1.32, 0.68)
PCB 118 −0.29 (−0.84, 0.26) −0.33 (−0.88, 0.23) −0.25 (−0.82, 0.33)
PCB 138 −0.32 (−0.71, 0.071) −0.26 (−0.65, 0.13) −0.18 (−0.62, 0.26)
PCB 153 −0.42* (−0.83, -0.0093) −0.38+ (−0.79, 0.035) −0.32 (−0.79, 0.15)
PCB 170 −1.58* (−3.12, -0.043) −1.54* (−3.07, -0.0027) −1.37 (−3.10, 0.36)
PCB 180 −0.57 (−1.28, 0.13) −0.74* (−1.46, -0.017) −0.69 (−1.55, 0.18)
PCB 187 −1.17 (−2.76, 0.42) −1.09 (−2.72, 0.54) −0.75 (−2.63, 1.14)
PCB 194 −1.18 (−4.55, 2.19) −2.32 (−5.69, 1.06) −2.15 (−5.87, 1.57)
PCB 203 0.065 (−1.83, 1.96) −0.55 (−2.47, 1.37) −0.16 (−2.19, 1.86)
1Parameter estimate for non-transformed PCB measure (adjusted: laboratory, natural log-transformed serum triglycerides and cholesterol).
2Parameter estimate for non-transformed PCB measure (adjusted: maternal race, age, employment status and infant sex, laboratory and natural log-transformed
serum triglycerides and cholesterol).
3Parameter estimate for non-transformed PCB measure (adjusted: p,p′-DDE, maternal race, age, employment status and infant sex, laboratory and natural
log-transformed serum triglycerides and cholesterol).
+significant at 0.05<p<0.10; *significant at p<0.05.
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which was more evident among boys. Exposure was
examined as the sum of nine individual PCB congeners,
with the majority overlapping with the ones we mea-
sured (118, 138, 153, 170, 180 and 187). We repeated
our adjusted birth weight analysis using this method and
found a non-significant increase in birth weight compar-
ing the 90th percentile of exposure to the 10th: β= 138 g
(95% CI −76, 351) and no gender differences. We also
note that while Hertz-Picciotto et al. also selected
mother-infant pairs from the CHDS, their sampling
strategy was much different from ours. To test their pri-
mary hypotheses, they selected infants with adverse neu-
rocognitive and neurosensory deficits. Because these
outcomes may be related to birth weight, their results
may not be surprising. Further, several key variables dif-
fered in their mother-infant pairs compared to the
CHDS source population, including maternal race (study
population more likely to be African-American), mater-
nal occupation (less likely to be a professional and more
likely to be a secretary/clerical worker), place of birth
(more likely to be born in the Southeastern US), mater-
nal alcohol consumption (more likely to consume lowlevels), maternal hypertension and pre-eclampsia (more
likely to be diagnosed), medications potentially related
to intra-uterine growth (less likely to be prescribed) and
father’s occupation and education (less likely to be a pro-
fessional or college graduate).
A recent meta-analysis of 15 studies in 12 European
cohorts examined the association between PCB 153 and
pregnancy outcomes including birth weight adjusted
for gestational age [35]. All cohorts were established
between 1990 and 2008 and thus had lower exposure
levels than in the CHDS; exposure was measured in
maternal and cord blood samples and in breast milk.
PCB 153 was used as the primary measure of exposure.
Low-level exposure to PCB 153 was associated with a
150 g decrease (95% CI −250, -50) in birth weight for
each 1-ng/mL increase in PCB 153 [35]. Although not
statistically significant, we found PCB 153 to be asso-
ciated with decreased birth weight in unadjusted analyses
(β=−61 g 95% CI −187, 65), however once adjusted for
covariates the negative association disappeared (Table 4).
Although the percentage of infants with birth weight
<2500 g was not provided in the manuscript, birth
weight ranged from 610 to 5500 g across the 7762
Figure 1 Adjusted mean length of gestation in tertiles of PCB group exposure. Adjusted mean weeks of gestation and 95% confidence
intervals for tertiles of PCB groupings achieving statistical significance at p<0.05 when comparing the middle or highest tertile to the lowest
(reference): PCBtotal (1a.), PCBdi (1b.) and PCB3 (1c.). Linear regression models were adjusted for maternal race, age, employment status and
infant sex, laboratory and log-transformed serum triglyceride and cholesterol. For PCB group 3, adjusted mean length of gestation decreases
significantly from the lowest category of exposure to both the middle (p<0.05) and to the highest category of exposure (p<0.01). Tertile
cut-points for total PCBs were 0.57-2.51, 2.52-3.50, and 3.51-12.29 ng/mL for tertiles 1, 2 and 3, respectively. Tertile cut-points for the di-ortho
substituted PCB group were 0.40-1.69, 1.69-2.34, and 2.34-8.98 for tertiles 1, 2 and 3, respectively. Tertile cut-points for PCB group 3 were 0.23-1.17,
1.18-1.61, and 1.61-5.29 for tertiles 1, 2 and 3, respectively. *p<0.05. **p<0.01.
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the 15 studies ranged from 3210 to 3750 g). Most infants
(98%) in our sample had birth weights above 2500 g and
our median birth weight was 3374 g.
We originally hypothesized that PCB congeners asso-
ciated with thyroid disruption (i.e. di- and tri-ortho sub-
stituted) would demonstrate stronger associations with
measures of fetal growth and gestational age. However,
our results demonstrate similar associations for all
groupings of PCBs as well as single congeners. Thus,
these results, along with the lack of evidence supporting
mediation, do not support our hypothesis that reduc-
tions in fetal growth are due to the thyroid disrupting
effects of PCBs.
Our study has many strengths. First, data were col-
lected prospectively, avoiding recall bias and problems
with temporality. High participation rates among those
invited to join the full CHDS study reduced the potential
for selection biases. We randomly selected our sample
from those with successive follow-up through adoles-
cence and with available serum, and those selected didnot appreciably differ for many maternal characteristics
from those who were not. Length of gestation did differ
between selected and non-selected participants and was
three days longer in the selected sample, likely making it
more difficult to find associations with reduced gesta-
tion. To nullify findings observed in the selected group,
shorter gestation infants in the non-selected sample
would need to have much lower PCB concentrations.
Second, the expected relationships between known
risk factors and adverse pregnancy outcomes (ex. smok-
ing and decreased birth weight) are present in our
sample, thus supporting the predictive validity of our
data. In addition, we controlled for maternal characteris-
tics known to be associated with PCB exposure or gesta-
tion in our sample. Inclusion of other known risk factors
(maternal BMI, smoking, parity) did not significantly
alter results (data not shown). Thus, confounding by
other maternal characteristics is unlikely to be respon-
sible for our findings.
Third, the wide range of exposure allowed examin-
ation of the association across PCB exposures from low
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ence in the birth outcomes between the exposure groups
of the highest tertile and the lowest tertile. We were
also able to discern whether the association varied by
type of PCB.
Fourth, our outcomes were considered as continuous
variables, rather than dichotomizing birth weight at
2500 g or length of gestation at 37 weeks, which we
believe has the statistical advantage of avoiding the
implied assumption of heterogeneity or risk within
dichotomies of birth outcomes [36].
Fifth, we found consistency in results using both linear
regression analysis and distribution free Cox propor-
tional hazards analysis. We believe the Cox proportional
hazards analysis is more useful than, in our case, a low-
powered analysis of preterm deliveries.
A particular strength of this study is that we were able
to test whether thyroid disruption mediates PCB effects
on length of gestation. The proposed mechanism is
likely due to the competitive binding by certain OCs to
transthyretin (TTR), the transport protein that carries
T4 from maternal circulation to the placenta [37]. There
is some evidence that PCBs can perturb thyroid function
[30] though there are also studies that do not support
this hypothesis [38]. However, we did not find any
evidence of mediation by maternal thyroid function in
either the birth weight or length of gestation analyses,
suggesting that PCBs impact fetal development via a dif-
ferent mechanism.
One possible explanation for our results, especially
those relating to PCB group 3, concerns the possible
relationship between these PCBs and cytochrome P450s,
which may activate toxic or carcinogenic compounds
[39]. A review article from 2011 indicates that CYP1A1
(a cytochrome P450 enzyme) expression is up-regulated
through the ligand-activated aryl hydrocarbon receptor
(AhR) [40]. Increased CYP1A1 activity through activated
AhR in placentas of smokers is associated with preg-
nancy complications, including premature birth and risk
of low birth weight [40].
Our study also has several limitations. First, we were
missing either laboratory data or data on covariates on
approximately 10% of our sample. However, compari-
sons of subjects with missing data to those without miss-
ing data did not show appreciable differences. Serum
samples from these women were collected between 1960
and 1963 [41] before PCBs were banned, which provides
the opportunity to examine a wide range of exposure.
However, it is unknown whether lower levels of exposure
currently observed in contemporary samples [42] have
the same effects. Thus, we may not be able to extrapolate
these findings to the current exposure levels. On the
other hand, our population allows us to explore relation-
ships that would be impossible to assess in contemporaryserum. Regardless, this study supports proof of concept
that PCBs can impact gestation.
Additionally, postpartum sera were used for the meas-
urement of OCs. This was for a practical reason, as
more sera were available for this time point. However,
because OCs have a long half-life in adipose tissue we
do not expect levels to vary during pregnancy. Indeed,
Longnecker et al. found that OC levels measured in
maternal blood collected serially in each trimester of
pregnancy and early postpartum were highly correlated
with minimal differences [43].
There may be concerns about multiple testing, how-
ever our analyses were specified a priori and analyses
that were secondary or exploratory were stated as such.
Although control for p,p′-DDE did not meaningfully
alter our findings, we cannot rule out the possibility of
confounding by a co-variable or other environmental
contaminant that we did not measure. For instance,
since the sera samples were stored at -20° C, we could
not measure n-3 or n-6 fatty acids, also found in sea
food, and which are beneficial to pregnancy outcomes.
Finally, although we do not have evidence to support
that higher chlorinated PCBs have greater associations
with fetal growth, we note that, in part, this can be
attributed to the high correlations between the individ-
ual PCB congeners (Additional file 1 Tables S5a-c).
Spearman correlation coefficients ranged from 0.57
(mono-ortho substituted and group 1b) to 0.98 (di-ortho
substituted and group 3) between PCB groupings (Add-
itional file 1 Table S5a.) and from 0.26 to 0.91 between
individual congeners (Additional file 1 Table S5b.). Fur-
ther, we considered the internal consistency among the
PCB congeners by calculating Cronbach’s alpha. High
internal consistency was found within the group of di-
ortho substituted PCBs as well as group 2b PCBs (Cron-
bach’s alpha: 0.94 and 0.91, respectively) and moderate
internal consistency was found for mono- and tri-ortho
substituted PCBs and for group 3 PCBs (Cronbach’s
alphas of 0.69, 0.76 and 0.81, respectively). This suggests
that exposure to all congeners was relatively universal
in the CHDS.
Conclusions
Our results have public health implications for infant
health, and potentially later adult health. Although
seemingly small for an individual, in our sample a popu-
lation shift in gestational age by age by a 1 and ½day
decrease would theoretically change the population
mean from 280 days to 278.5 days, and result in a shift
in the proportion of preterm births from 3.5% to 4.7%.
Further, we note that gestational lengths in the 37
to 39 week range are also associated with increased mor-
bidity in other studies [44]. Our results also may fur-
ther inform current research on more contemporary
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flame retardants, and provide strategies for the study of
potential adverse pregnancy findings following exposure.
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